Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer

Molecular Vision

Volumn 9, Issue , 2003, Pages 465-472

  Zhang, Yun ^a   Schlachetzki, Felix ^a,b   Li, Jian Yi ^a   Boado, Ruben J ^a   Pardridge, William M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; IMMUNOLIPOSOME; INSULIN RECEPTOR; LUCIFERASE; MONOCLONAL ANTIBODY; OPSIN; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD RETINA BARRIER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG CAPSULE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE TARGETING; HISTOCHEMISTRY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PHOTORECEPTOR CELL; PRIMATE; PROMOTER REGION; RETINA CELL; RHESUS MONKEY; SIMIAN VIRUS 40; TARGET ORGAN; TRANSGENE;

ANIMALS; ANTIBODIES, MONOCLONAL; BETA-GALACTOSIDASE; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE TARGETING; GENE TRANSFER TECHNIQUES; HISTOCYTOCHEMISTRY; INJECTIONS, INTRAVENOUS; LIPOSOMES; LUCIFERASES; MACACA MULATTA; MICROSCOPY, CONFOCAL; OPSIN; ORGAN SPECIFICITY; PLASMIDS; POLYETHYLENE GLYCOLS; PROMOTER REGIONS (GENETICS); RECEPTOR, INSULIN; RETINA; SIMIAN VIRUS 40; TRANSGENES;

EID: 0347555450     PISSN: 10900535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Hauswirth WW, Beaufrere L. Ocular gene therapy: quo vadis? Invest Ophthalmol Vis Sci 2000; 41:2821-6.
2. Dejneka NS, Bennett J. Gene therapy and retinitis pigmentosa: advances and future challenges. Bioessays 2001; 23:662-8.
3. Hauswirth WW, McInnes RR. Retinal gene therapy 1998: summary of a workshop. Mol Vis 1998; 4:11 .
4. Bennett J, Maguire AM, Cideciyan AV, Schnell M, Glover E, Anand V, Aleman TS, Chirmule N, Gupta AR, Huang Y, Gao GP, Nyberg WC, Tazelaar J, Hughes J, Wilson JM, Jacobson SG. Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci U S A 1999; 96:9920-5.
5. Flannery JG, Zolotukhin S, Vaquero MI, LaVail MM, Muzyczka N, Hauswirth WW. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc Natl Acad Sci U S A 1997; 94:6916-21.
6. Zhu C, Zhang Y, Pardridge WM. Widespread expression of an exogenous gene in the eye after intravenous administration. Invest Ophthalmol Vis Sci 2002; 43:3075-80.
7. Shi N, Zhang Y, Zhu C, Boado RJ, Pardridge WM. Brain-specific expression of an exogenous gene after i.v. administration. Proc Natl Acad Sci U S A 2001; 98:12754-9.
8. Shi N, Boado RJ, Pardridge WM. Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes. Pharm Res 2001; 18:1091-5.
9. Davis AA, Hunt RC. Transferrin is made and bound by photoreceptor cells. J Cell Physiol 1993; 156:280-5.
10. Yefimova MG, Jeanny JC, Guillonneau X, Keller N, Nguyen-Legros J, Sergeant C, Guillou F, Courtois Y. Iron, ferritin, transferrin, and transferrin receptor in the adult rat retina. Invest Ophthalmol Vis Sci 2000; 41:2343-51.
11. Naeser P. Insulin receptors in human ocular tissues. Immunohistochemical demonstration in normal and diabetic eyes. Ups J Med Sci 1997; 102:35-40.
12. Gosbell AD, Favilla I, Baxter KM, Jablonski P. Insulin receptor and insulin receptor substrate-I in rat retinae [published erratum in: Clin Experiment Ophthalmol 2000; 28:443]. Clin Experiment Ophthalmol 2000; 28:212-5.
13. Pardridge WM, Kang YS, Buciak JL, Yang J. Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate. Pharm Res 1995; 12:807-16.
14. Zhang Y, Schlachetzki F, Pardridge WM. Global non-viral gene transfer to the primate brain following intravenous administration. Mol Ther 2003; 7:11-8.
15. Ford SM. Systematics of the new world monkeys. In: Erwin J, Swindler DR, editors. Comparative primate biology I: Systematics, evolution, and anatomy. New York: Alan R. Liss; 1986. p. 23-135.
16. Zack DJ, Bennett J, Wang Y, Davenport C, Klaunberg B, Gearhart J, Nathans J. Unusual topography of bovine rhodopsin promoter-lacZ fusion gene expression in transgenic mouse retinas. Neuron 1991; 6:187-99.
17. Boado RJ, Pardridge WM. Ten nucleotide cis element in the 3′-untranslated region of the GLUT1 glucose transporter mRNA increases gene expression via mRNA stabilization. Brain Res Mol Brain Res 1998; 59:109-13.
18. Shi N, Pardridge WM. Noninvasive gene targeting to the brain. Proc Natl Acad Sci U S A 2000; 97:7567-72.
19. Zhang Y, Jeong Lee H, Boado RJ, Pardridge WM. Receptor-mediated delivery of an antisense gene to human brain cancer cells. J Gene Med 2002; 4:183-94.
20. Zhang Y, Zhu C, Pardridge WM. Antisense gene therapy of brain cancer with an artificial virus gene delivery system. Mol Ther 2002; 6:67-72.
21. Zhang Y, Boado RJ, Pardridge WM. Marked enhancement in gene expression by targeting the human insulin receptor. J Gene Med 2003; 5:157-63.
22. Haruta M, Kosaka M, Kanegae Y, Saito I, Inoue T, Kageyama R, Nishida A, Honda Y, Takahashi M. Induction of photoreceptor-specific phenotypes in adult mammalian iris tissue. Nat Neurosci 2001; 4:1163-4.
23. Kaneko R, Sueoka N. Tissue-specific versus cell type-specific expression of the glial fibrillary acidic protein. Proc Natl Acad Sci U S A 1993; 90:4698-702.
24. Galou M, Pournin S, Ensergueix D, Ridet JL, Tchelingerian JL, Lossouarn L, Privat A, Babinet C, Dupouey P. Normal and pathological expression of GFAP promoter elements in transgenic mice. Glia 1994; 12:281-93.
25. Zhang Y, Calon F, Zhu C, Boado RJ, Pardridge WM. Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism. Hum Gene Ther 2003; 14:1-12.
26. Stoll SM, Sclimenti CR, Baba EJ, Meuse L, Kay MA, Calos MP. Epstein-Barr virus/human vector provides high-level long-term expression of alpha1-antitrypsin in mice. Mol Ther 2001; 4:122-9.
27. Zhang YF, Boado RJ, Pardridge WM. Absence of toxicity of chronic weekly intravenous gene therapy with pegylated immunoliposomes. Pharm Res. In press 2003.
28. Coloma MJ, Lee HJ, Kurihara A, Landaw EM, Boado RJ, Morrison SL, Pardridge WM. Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor. Pharm Res 2000; 17:266-74.